psychiatryRounds

Connecting Psychiatry - Expert community for all mental health professionals

(PSYCHIATRIC TIMES) - Comorbidity of psychiatric syndromes is quite common—in a 12-month period, almost 50% of adults in the United States with any psychiatric disorder had 2 or more disorders.1 The prevalence of comorbid anxiety disorder and major depressive disorder (MDD) is frequent and perhaps as high as 60%.2 It may be higher if significant but subsyndromal symptoms are included in analyses.3 This is far greater than the 2% or less co-occurrence that would be expected by chance. Although panic disorder (PD) and generalized anxiety disorder (GAD) have been most studied as part of an anxiety-depression comorbid state, all or almost all of the anxiety disorders appear to show comorbidity with at least depressive symptoms if not full MDD.

The National Comorbidity Survey Replication1 reported that in a 12-month period, the prevalence for an anxiety disorder was about 18%, and for a mood disorder it was 9.5%. Lifetime prevalences for any anxiety disorder and MDD were approximately 29% and 16.6%, respectively.4 Assuming a (perhaps conservative) 50% comorbidity rate, between 5% and 9% of the adult population has comorbid depression-anxiety in a 12-month period.

The impact of comorbid depression and anxiety is substantial. As demonstrated by the Global Burden of Disease study, neuropsychiatric disorders accounted for more than 13% of all medical disability worldwide and for more than 27% of all noncommunicable disease in 2005.5 Depression alone produced 10% to 12% of all disability from noncommunicable disease and approximately 5% of all disability (noncommunicable, communicable, injury). Thus, comorbid anxiety and depression may account for as much as 2% to 4% of all medical disability worldwide. In addition, depression (and, thus, comorbid depression and anxiety) is associated with other psychiatric and nonpsychiatric medical conditions (eg, cardiovascular disease, diabetes, HIV/AIDS, maternal and reproductive-related syndromes, and psychosomatic illnesses), with their resulting socioeconomic costs.5
Risk factors and prognoses

There has been little research on risk factors that predict the development of comorbid anxiety and depression compared with risk factors for either disorder alone. However, the high rate of comorbidity indicates that the simple occurrence of one disease state should be considered a predisposing factor for the development of the other. Psychosocial and situational difficulties also appear to be risk factors for the development of comorbid anxiety and depression.6 Familial/genetic studies reported different results, partly determined by the anxiety disorder under consideration.6 For example, MDD and GAD appear to be related to the same genetic factors, while MDD and PD are familially independent.7-9 Gender may also play a role, because women have a higher risk than men for both disorders.4

Age is another consideration. Patients with anxiety disorders have a much earlier median age at onset than do those with mood disorders (age 11 years vs age 30 years).4 As would be expected, onset of anxiety usually predates onset of depression in patients with this comorbidity.6,10 However, the earlier onset of anxiety disorders does not necessarily infer causality.

The expected prognosis for patients with comorbid anxiety and depressive disorders is poorer than that for either disorder alone. These patients have greater severity of symptoms, increased risk of suicidality, a more chronic and persistent course, and more functional impairment. This syndrome is also more difficult to treat, with longer time to remission and need for increased medication.6,11,12
Biological studies

There are several possible explanations for this high rate of comorbidity.13 First, the present DSM-IV diagnostic criteria tend to overlap, raising the likelihood that a person meeting criteria for one disorder has an increased probability of having the other. For example, depressive ruminations are similar to the obsessional thinking/worry seen in GAD; poor sleep quality and difficulty in concentrating occur in both depression and posttraumatic stress disorder; and phobic avoidance can be mistaken for depressive loss of energy or fatigue. A second possibility is that the disorders are etiologically different, but symptom episodes are provoked by related environmental events (ie, stressors), such as threat (anxiety) and loss (depression).14 The third possibility is that the underlying biologies of the disorders are the same or are highly overlapping; this is related to the first possible explanation. An understanding of the pathophysiology of depressive and anxiety disorders is necessary to address the first and third reasons.

For full article, please visit:
http://www.psychiatrictimes.com/anxiety/article/10168/53896

Views: 4

Comment

You need to be a member of psychiatryRounds to add comments!

Join psychiatryRounds


psychiatryRounds Social Media

Sponsors

CMEinfo: Board Reviews in Anesthesia, Cardiology, Internal Medicine, Radiology

© 2019   Created by PsychiatryRounds Team.   Powered by

Badges  |  Report an Issue  |  Terms of Service